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Expanded Abstract 
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mortality in patients receiving massive transfusions at a 
combat support hospital. J Trauma 2007, 63:805-813 [1]. 
Background 
Patients with severe traumatic injuries often present with 
coagulopathy and require massive transfusion. The risk of 
death from hemorrhagic shock increases in this population. 
To treat the coagulopathy of trauma, some have suggested 
early, aggressive correction using a 1:1 ratio of plasma to 
red blood cell (RBC) units.    
Methods 
Objective: To determine whether the ratio of plasma to 
RBCs transfused would affect survival by decreasing death 
from hemorrhage. 
Design: Retrospective chart review. 
Setting:  United States Army combat support hospital in 
Iraq. 
Subjects: 246 patients who received a massive transfusion 
(≥10 units of RBCs in 24 hours) from November 2003 to 
September 2005. Three groups of patients were constructed 
according to the plasma to RBC ratio transfused during 
massive transfusion. 
Intervention: None.   
Outcome: Hospital mortality rates and the cause of death 
were compared among groups. Multivariable logistic 
regression was used to determine the independent 
association between plasma to RBC ratio and hospital 
mortality. 
Results  
For the low ratio group the plasma to RBC median ratio was 
1:8 (interquartile range (IQR), 0:12-1:5), for the medium 
ratio group, 1:2.5 (IQR, 1:3.0-1:2.3), and for the high ratio 
group, 1:1.4 (IQR, 1:1.7-1:1.2) (p<0.001). Median Injury 
Severity Score (ISS) was 18 for all groups (IQR, 14-25). For 
low, medium, and high plasma to RBC ratios, overall 
mortality rates were 65%, 34%, and 19%, (p<0.001); and 
hemorrhage mortality rates were 92.5%, 78%, and 37%, 
respectively (p < 0.001). Upon logistic regression, plasma to 
RBC ratio was independently associated with survival (odds 
ratio 8.6, 95% confidence interval 2.1-35.2). 
Conclusions 
In patients with combat-related trauma requiring massive 
transfusion, a high 1:1.4 plasma to RBC ratio is 
independently associated with improved survival to hospital 
discharge, primarily by decreasing death from hemorrhage. 
For practical purposes, massive transfusion protocols 
should utilize a 1:1 ratio of plasma to RBCs for all patients 
who are hypocoagulable with traumatic injuries. 
 
Commentary 
On 3 October 1993, two hundred American soldiers caught 
during a daytime raid participated in a firefight in the streets 
of Mogadishu, Somalia. In the hours before extraction, 
fourteen men died of their wounds in the field; more 
succumbed first at the combat hospital and later in 
Germany. That single event prompted a review by military 
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medical personnel of existing resuscitation practices, 
rekindling debates begun at the time of World War I [2]. As 
difficult as it is to imagine today, during World War I there 
was commonly no preoperative resuscitation in combat 
trauma. By World War II, resuscitation with colloid and blood 
had become the standard approach. Only during Vietnam 
did the work of Moyer, Shires, Moss, and others [2] lead to 
the widespread use of large-volume resuscitation with 
isotonic crystalloids, with guidelines recommending the 
infusion of crystalloid and blood in a ratio of three to one. As 
pre-hospital care improved, attention shifted to 
consideration of other interventions that might decrease 
mortality among those suffering massive blood loss, fixing 
on the so called "bloody lethal triad" of hypothermia, 
acidosis, and coagulopathy [3], the later of which is due in 
part to both dilution and consumption of coagulation factors 
[4].  
The 1980s saw the advent of damage control surgery, in 
which the restoration of normal anatomy is deferred to limit 
the progression of coagulopathy and blood loss. This 
approach improved survival rates for patients with massive 
traumatic hemorrhage from 30% to around 50% to 60%, 
where they remained to the turn of the century [3]. When 
John Holcomb issued a statement on behalf of the United 
States Armed Forces in January 2007 announcing a change 
in field practices to incorporate the use of plasma as the 
primary resuscitation fluid [5], he articulated an impatience 
of the trauma community at the failure to make greater 
progress in reducing mortality among those at "the outer 
limits of survivability."  
This apparent paradigm shift drew on an emerging body of 
work suggesting that management of the coagulopathy of 
trauma required a proactive, rather than reactive, approach. 
Using a computer model based on data from severely 
injured trauma patients, Hirschberg and colleagues found 
that patients who arrived to the emergency department with 
a systolic blood pressure of 70 mmHg had already lost 67% 
of their blood volume [6]. Preventing the development of 
profound and often refractory coagulopathy in these 
patients required plasma infusion before, instead of after, 
the patient became coagulopathic. Gonzalez and 
colleagues studied the existing trauma massive transfusion 
protocol at Memorial Hospital in Houston, which at that time 
required the infusion of six units of RBCs prior to use of 
plasma [7]. The authors found that coagulopathy, which was 
present on admission, remained after the initial pre-ICU 
resuscitation and that even after the administration of a 
mean of 10 units of plasma in the ICU, patients remained 
coagulopathic. The authors suggested that to correct 
coagulopathy and decrease RBC requirements, plasma 
should be given earlier and in a plasma to RBC ratio of 1:1. 
In a retrospective review of trauma patients who underwent 
emergent surgery at an urban Level I trauma center, 
Duchesne and colleagues found a significant mortality 
difference in patients who were transfused with >10 units of 
RBCs when plasma accompanied the RBCs in a 1:1 as 
opposed to 1:4 ratio (26% vs. 87.5%, p=0.0001) [8]. In a 
before and after study, Johansson and colleagues 
compared survival of patients undergoing surgery for a 
ruptured abdominal aortic aneurysm after implementing a 
transfusion strategy that included proactive administration of 
platelets together with plasma given in a 1:1 ratio with RBCs 
[9]. The authors found that patients treated under the new 
strategy had fewer postoperative transfusions (RBC units, 2 
vs. 6, p<0.01), and higher 30-day survival (66% vs. 44%, 
p=0.02).  
In the current study, Borgman and colleagues examined the 
use of plasma and RBCs in severely injured patients in a 
combat support hospital in Iraq between November 2003 
and September 2005 [1]. In this retrospective cohort study, 
the authors identified 246 patients that received massive 
transfusion,  ≥ 10 units of RBCs in 24 hours, in the Joint 
Theater Trauma Registry; a database that prospectively 
captures data from the point of injury through discharge 
from military treatment facilities. Patients were grouped 
based on the ratio of plasma to RBCs received during 
massive transfusion: a low ratio group (median ratio 1:8); a 
medium ratio group (median ratio 1:2.5); and a high ratio 
group (median ratio 1:1.4). Initial Injury Severity Scores 
were similar between groups as was the proportion with 
either blunt or penetrating trauma. However, severe thoracic 
injuries were more common in the low ratio group. All 
baseline vital signs and laboratory results were comparable, 
with the exception of hemoglobin, which was lower in the 
low ratio group compared with the medium and high groups 
(9.4 mg/dL vs. 10.8 mg/dL vs. 10.9 mg/dL, p<0.05). Not 
surprisingly, there were differences in hourly infusion rates 
and total volume of various resuscitation products given. 
Low ratio patients received higher hourly rates of 
crystalloids and RBCs, lower hourly rates and total volume 
of plasma, and were less likely to receive platelets, 
cryoprecipitate, and recombinant Factor VIIa (fFVIIa). In 
univariate analysis, as the ratio of plasma to RBCs received 
increased, hospital mortality decreased in an apparent 
dose-response fashion (65% vs. 34% vs. 19%, p<0.001). 
Nonsurvivors in the low and medium ratio groups died 
significantly sooner than those in the high ratio group 
(median time to death, 2 hours vs. 4 hours vs. 38 hours, 
p<0.001). The relationship between plasma to RBC ratio 
and overall mortality persisted after adjusting for potential 
confounders, including Abbreviate Injury Scale subscores, 
systolic blood pressure, base deficit, hemoglobin levels, and 
when patients with thoracic trauma, neurotrauma, or those 
receiving fFVIIa were excluded from the analysis. 
As with any observational study, this work can only show 
associations between exposure and outcome and cannot 
prove cause and effect. The excess early deaths observed 
in the low ratio group might a product of having received 
less plasma. Conversely, dying early might prevent subjects 
from having a chance to receive large quantities of plasma, 
which typically must be thawed prior to use. Though the 
authors have considered a large number of patient and 
treatment-related variables and adjusted for differences 
between groups in their analyses, residual confounding due 
to unmeasured factors associated with survival may still 
exist. It would have been helpful for the authors to have 
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included a propensity score for the ratio of plasma to RBCs 
received in their analyses, though even this would not 
completely remove the possibility of indication bias. Finally, 
the most problematic challenge to this work is one of 
generalizeablity, since the patient population consisted of 
young, otherwise healthy men suffering primarily 
penetrating injuries from combat trauma. Whether these 
findings translate to civilian trauma settings or to non-
traumatic cases of massive hemorrhage, such as post-
operative patients or medical patients with gastrointestinal 
hemorrhage, remains to be seen. 
Since publication of this manuscript, additional work 
published in abstract form supports its findings. In a single 
center study, Gonzalez and colleagues found a reduction of 
hospital mortality from 30% to 15% in trauma patients 
receiving massive transfusion after the institution of an early 
goal directed therapy protocol calling for a 1:1 ratio of 
plasma to RBCs within the first 6 hours of injury [10]. Sperry 
and colleagues retrospectively examined plasma to RBC 
ratios in a multi-center prospective cohort study evaluating 
clinical outcomes in blunt injured adults with hemorrhagic 
shock. In those requiring at least 8 units of RBCs within the 
first 12 hours post-injury, higher plasma to RBC ratio was 
associated with significantly reduced hospital mortality in a 
dose-response relationship [11]. Additional analysis of these 
data revealed that a ratio of  ≥ 1:1.5 was independently 
associated with lower hospital mortality, but higher risk of 
acute respiratory distress syndrome [12], the latter of which 
may be a product of increased survival or of the additional 
plasma itself.  
It is important to note that transfusion of plasma is not 
without risk, including infection, transfusion-related acute 
lung injury, acute allergic and anaphylactic reactions, 
hemolysis, and fluid overload [4].  Furthermore, wide-scale 
adoption of 1:1 plasma to RBC ratios would have important 
implications for the blood supply. Yet, only 1% of civilian 
trauma patients require massive transfusion, so perhaps the 
impact would be less than anticipated. 
Recommendation 
In massively injured patients, the prevention and/or 
treatment of coagulopathy with plasma administered in a 1:1 
ratio with RBCs has a certain degree of face validity and 
growing support in observational studies. The increased use 
of plasma, however, is not without risk and may have 
important implications for blood supply management. 
Whether similar associations might also be seen in patients 
bleeding from non-traumatic injuries is unknown, with the 
exception of those bleeding from ruptured abdominal aortic 
aneurysms. Prospective trials investigating the optimal 
plasma to RBC ratio in patients requiring massive 
transfusion are warranted. 
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